Notably, treatment with a COMP-derived peptidomimetic (CCPep24) that mimics COMP’s interaction with integrin α5 reduced endothelial activation and atherogenesis in vivo [279], indicating the protective role of COMP in EC inflammation and atherosclerosis. Here, COMP is linked to atherosclerosis.